Article Details
Retrieved on: 2022-12-14 18:07:01
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Replimune is a Nasdaq-listed biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic platform that target cancer ...
Article found on: www.morganlewis.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here